Editas Medicine Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St set for higher open but weekly losses loom
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Editas Medicine (EDIT) IPO Opens Flat
February 3, 2016 11:03 AM ESTToday's IPO for Editas Medicine (NASDAQ: EDIT) opened for trading at $16.10 after pricing 5,900,000 shares at $16 per share, the low end of the expected $16-$18 range.
The offering was led by Morgan Stanley, JP Morgan, Cowen and JMP Securities.
Editas Medicine is a... More
